Human FAM62B (ESYT2) activation kit by CRISPRa

CAT#: GA111530

ESYT2 CRISPRa kit - CRISPR gene activation of human extended synaptotagmin 2



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal Anti-ESYT2 Antibody
    • 100 ul

CNY 5,250.00


ESYT2 (Myc-DDK-tagged)-Human extended synaptotagmin-like protein 2 (ESYT2)
    • 10 ug

CNY 6,544.00
CNY 7,130.00


FAM62B Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol ESYT2
Locus ID 57488
Kit Components

GA111530G1, FAM62B gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA111530G2, FAM62B gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA111530G3, FAM62B gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_020728, NM_001367773
Synonyms CHR2SYT; E-Syt2; FAM62B
Summary Tethers the endoplasmic reticulum to the cell membrane and promotes the formation of appositions between the endoplasmic reticulum and the cell membrane. Binds glycerophospholipids in a barrel-like domain and may play a role in cellular lipid transport. Plays a role in FGF signaling via its role in the rapid internalization of FGFR1 that has been activated by FGF1 binding; this occurs most likely via the AP-2 complex.[UniProtKB/Swiss-Prot Function]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...